当前位置:首页 - 行情中心 - 恒瑞医药(600276) - 财务分析

恒瑞医药

(600276)

  

流通市值:3940.31亿  总市值:4099.80亿
流通股本:63.79亿   总股本:66.37亿

恒瑞医药(600276)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润57.60亿元,每股收益0.89元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益6003251.80万元,未分配利润3834256.84万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产6832754.05万元,负债829502.25万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入23,188,081,928.7715,761,193,628.97,205,611,122.7227,984,605,342.06
营业总成本16,915,649,809.7610,900,173,954.425,134,690,588.221,008,000,532.03
其他经营收益
营业利润6,624,512,439.115,158,892,665.212,085,980,911.667,490,632,003.88
利润总额6,412,007,794.735,050,934,208.952,075,603,711.837,169,689,995.75
净利润5,760,235,152.024,454,670,657.211,876,441,961.326,336,994,647.53
每股收益
其他综合收益20,467,114.3526,151,612.622,346,805.44-624,026.11
综合收益总额5,780,702,266.374,480,822,269.831,878,788,766.766,336,370,621.42
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计51,399,537,865.5146,760,288,804.8835,969,765,897.935,314,927,240.59
非流动资产:
非流动资产合计16,928,002,620.2716,133,228,343.6615,323,015,793.0114,820,718,063.51
资产总计68,327,540,485.7862,893,517,148.5451,292,781,690.9150,135,645,304.1
流动负债:
流动负债合计7,851,588,815.913,465,048,543.013,362,881,494.13,633,595,722.67
非流动负债:
非流动负债合计443,433,667398,670,566.39380,131,139.07411,798,848.12
负债合计8,295,022,482.913,863,719,109.43,743,012,633.174,045,394,570.79
所有者权益(或股东权益):
归属于母公司股东权益合计59,504,250,787.1958,464,831,216.7846,987,059,491.0845,519,861,860.32
股东权益合计60,032,518,002.8759,029,798,039.1447,549,769,057.7446,090,250,733.31
负债和股东权益合计68,327,540,485.7862,893,517,148.5451,292,781,690.9150,135,645,304.1
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计26,972,822,783.3816,123,794,040.476,301,936,538.2928,468,881,744.13
经营活动现金流出小计17,862,392,493.1111,823,340,789.075,746,762,449.7821,046,128,705.42
经营活动产生的现金流量净额9,110,430,290.274,300,453,251.4555,174,088.517,422,753,038.71
投资活动产生的现金流量:
投资活动现金流入小计188,195,561.47182,832,015.64170,354,321.21679,892,183.13
投资活动现金流出小计1,714,462,484.691,267,564,947.42702,031,901.522,591,877,899.36
投资活动产生的现金流量净额-1,526,266,923.22-1,084,732,931.78-531,677,580.31-1,911,985,716.23
筹资活动产生的现金流量:
筹资活动现金流入小计10,780,273,195.0610,351,937,892.28-799,909,380.08
筹资活动现金流出小计2,689,252,803.882,312,442,891.87661,059,213.922,350,499,405.96
筹资活动产生的现金流量净额8,091,020,391.188,039,495,000.41-661,059,213.92-1,550,590,025.88
汇率变动对现金及现金等价物的影响-146,577,748.5848,287,663.4729,624,153.667,400,551.34
现金及现金等价物净增加额15,528,606,009.6511,303,502,983.5-607,938,552.063,967,577,847.94
期末现金及现金等价物余额39,767,708,127.3135,542,605,101.1623,631,163,565.624,239,102,117.66
补充资料:
现金及现金等价物的净增加额-11,303,502,983.5-3,967,577,847.94
最新报告期:2025-11-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹1.341.651.982025-11-10
兴业证券孙媛媛,王佳慧1.321.641.802025-11-10
东方证券伍云飞,傅肖依1.321.511.722025-11-10
首创证券王斌1.351.591.852025-11-05
中信建投袁清慧,贺菊颖1.331.541.812025-11-02
TOP↑